Sort
23,748 grants matching “melanoma”
Southwest Oncology Group
$218,165Wayne State University · U10 · FY2005 · CA
Integrated PhD Training Program in Cancer Biology
$218,089Kenneth J Marians · Sloan-Kettering Inst Can Research · T90 · FY2007 · DA
Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome
$218,089Martin McCarter · University Of Colorado Denver · R21 · FY2021 · CA
Proteomic signatures to predict drug response in cancer
$218,089Shao-En Ong · University Of Washington · R21 · FY2024 · CA
Metabolic Engineering of Cancer for Immunotargeting
$218,025Case Western Reserve University · R01 · FY2003 · CA
Metabolic Engineering of Cancer for Immunotargeting
$218,025Case Western Reserve University · R01 · FY2004 · CA
HEPARIN-BINDING PEPTIDES FROM CELL ADHESION PROTEINS
$218,015University Of California Riverside · R01 · FY2001 · HL
Immunotherapy of Uveal Melanoma using PRAME Vaccine in Combination with Adoptive T Cell Therapy
$218,011Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Targeting an MT1-MMP/MMP2 axis in melanoma by a novel MT1-MMP/MMP2 inhibitor
$217,926Barbara Bedogni · Case Western Reserve University · R21 · FY2015 · CA
Clinical Research
$217,912Raymond P Perez · Dartmouth College · P30 · FY2008 · CA
Administrative Core
$217,902Meenhard Herlyn · Wistar Institute · P50 · FY2021 · CA
HEPARIN-BINDING PEPTIDES FROM CELL ADHESION PROTEINS
$217,901University Of California Riverside · R01 · FY2002 · HL
Improving Accuracy of Next-Generation Microscopy for Early Stage Metastatic Melanoma Detection
$217,875Warren S Warren · Duke University · R21 · FY2024 · CA
Comparing NK cell profiles within melanoma tumors and pregnancy: Implications for novel immunotherapies
$217,863Paul John Norman · University Of Colorado Denver · R21 · FY2025 · CA
Receptor Crosstalk in HNSCC Metastatic Progression
$217,832Steven A. Rosenzweig · Medical University Of South Carolina · R01 · FY2014 · CA
ANOIKIS EFFECTORS AS DRIVERS OF METASTATIC MELANOMA
$217,826Narendra Wajapeyee · Yale University · R21 · FY2016 · CA
Identifying drug synergistic with cancer immunotherapy
$217,810Avinash Das Sahu · University Of New Mexico Health Scis Ctr · R00 · FY2024 · CA
Evaluate the antiangiogenic properties of mda-7/IL-24
$217,771Rajagopal Ramesh · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Development of Mouse and Humanized Models to Study Sex Disparities in Tumor Progression and Treatment of NSCLC
$217,738Joseph William Landry · Virginia Commonwealth University · R21 · FY2023 · CA
HEPARIN-BINDING PEPTIDES FROM CELL ADHESION PROTEINS
$217,734University Of California Riverside · R01 · FY2003 · HL
Hepatitis C viral sensing by non-parenchymal liver cells (NPC)
$217,728Hugo R Rosen · University Of Colorado Denver · R21 · FY2013 · AI
Multiple Antigen-Engineered DC Immunization and IFNalpha-2b Boost for Metastatic Melanoma
$217,669Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · CA
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER
$217,517James P Allison · Sloan-Kettering Inst Can Research · P50 · FY2010 · CA
PET IMAGING IN THE SURGICAL MANAGEMENT OF MELANOMA
$217,484Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2000 · CA
Deciphering MDSC function for GBM targeting
$217,469Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS